Mount Sinai Tisch Cancer Institute — New York, New York

Mount Sinai Tisch Cancer Institute is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mount Sinai Tisch Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia.

Sponsors: Kite, A Gilead Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Tisch Cancer Institute?

Mount Sinai Tisch Cancer Institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Tisch Cancer Institute conducted?

Mount Sinai Tisch Cancer Institute has 1 clinical trials on record. Their work covers Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia.

Is Mount Sinai Tisch Cancer Institute accredited by Crixeo Health?

Mount Sinai Tisch Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Tisch Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.